Thermo Fisher's 0.96% Drop on $1.11 Billion Volume Drags It to 86th in U.S. Trading Rankings

Thermo Fisher Scientific (TMO) closed on September 22, 2025, , , . . Market participants observed mixed liquidity conditions as institutional positioning and sector rotation dynamics influenced short-term price action.

Recent developments highlighted regulatory scrutiny intensifying across the life sciences sector. While no direct regulatory actions were announced against TMO, broader sector-wide compliance reviews and supply chain adjustments in diagnostic reagent markets created a risk-off sentiment. Analysts noted that TMO's exposure to government-funded R&D programs remains a key vulnerability amid shifting fiscal policies.

showed bearish divergence in short-term momentum, with price failing to hold above key moving averages. indicated elevated bearish positioning, though open interest in derivative contracts remained stable. Market structure analysis suggested that the selloff was driven by profit-taking rather than fundamental deterioration.

To make sure I implement this precisely (and in a way our back-testing engine can support), could you please confirm a couple of details? 1. Market universe • U.S. listed stocks (e.g., all NYSE + NASDAQ) • or a narrower universe (e.g., S&P 500 constituents)? 2. , , ? , , ? 3. , ? • Equal-weighted across the 500 names (i.e., ? 4. Benchmark (if any) you’d like to compare against (e.g., . Once I have these points, I can set up the data-pull plan and run the back-test for you.